Literature DB >> 15709325

Speech-based E-mail and driver behavior: effects of an in-vehicle message system interface.

A Hamish Jamson1, Stephen J Westerman, G Robert J Hockey, Oliver M J Carsten.   

Abstract

As mobile office technology becomes more advanced, drivers have increased opportunity to process information "on the move." Although speech-based interfaces can minimize direct interference with driving, the cognitive demands associated with such systems may still cause distraction. We studied the effects on driving performance of an in-vehicle simulated "E-mail" message system; E-mails were either system controlled or driver controlled. A high-fidelity, fixed-base driving simulator was used to test 19 participants on a car-following task. Virtual traffic scenarios varying in driving demand. Drivers compensated for the secondary task by adopting longer headways but showed reduced anticipation of braking requirements and shorter time to collision. Drivers were also less reactive when processing E-mails, demonstrated by a reduction in steering wheel inputs. In most circumstances, there were advantages in providing drivers with control over when E-mails were opened. However, during periods without E-mail interaction in demanding traffic scenarios, drivers showed reduced braking anticipation. This may be a result of increased cognitive costs associated with the decision making process when using a driver-controlled interface when the task of scheduling E-mail acceptance is added to those of driving and E-mail response. Actual or potential applications of this research include the design of speech-based in-vehicle messaging systems.

Entities:  

Mesh:

Year:  2004        PMID: 15709325     DOI: 10.1518/hfes.46.4.625.56814

Source DB:  PubMed          Journal:  Hum Factors        ISSN: 0018-7208            Impact factor:   2.888


  1 in total

1.  Cell Phone Use While Driving: Prospective Association with Emerging Adult Use.

Authors:  Neha Trivedi; Denise Haynie; Joe Bible; Danping Liu; Bruce Simons-Morton
Journal:  Accid Anal Prev       Date:  2017-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.